Literature DB >> 16707777

Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies.

Larry J Seidman1, Anthony J Giuliano, Christopher W Smith, William S Stone, Stephen J Glatt, Eric Meyer, Stephen V Faraone, Ming T Tsuang, Barbara Cornblatt.   

Abstract

Siblings and offspring of persons with schizophrenia carry elevated genetic risk for the illness and manifest attentional and memory impairments. Because less is known about other neuropsychological functions and their specificity in adolescents, we conducted a genetic high-risk (HR) study of schizophrenia (HR-SCZ) and affective psychosis (HR-AFF). Participants (ages 12-25) were from the Harvard Adolescent High-Risk and Hillside Family studies, including 73 HR-SCZ, 18 HR-AFF, and 84 community controls (CCs) recruited in metropolitan Boston and New York. Groups were compared on overall neurocognitive functioning, 6 domains, and 13 test scores, controlling for age, parental education, and correlated data within families. The HR-SCZ group was significantly impaired overall, while the HR-AFF group demonstrated a trend toward overall impairment. HR-SCZ subjects showed significantly lower Verbal Ability (d = .73) and Executive Functioning/Working Memory (d = .47) than CCs. HR-AFF subjects showed reduced Verbal Ability (d = .64) compared to CCs. Excluding 12 CCs with a parental history of depression (without psychosis) led to larger differences between HR and CC groups across domains. Moreover, HR-SCZ and CC group differences in Verbal Memory (d = .39) and Visual-Spatial (d = .34) became statistically significant. There were no significant differences between HR-SCZ and HR-AFF groups. Data support a modest neuropsychological deficit in persons at genetic HR for psychosis, with a broader range of deficits in HR-SCZ. Future work should assess the relationship of neurocognition to adaptive functioning and possible onset of psychosis in HR samples. Ascertainment criteria for controls may markedly influence results and interpretation of group differences.

Entities:  

Mesh:

Year:  2006        PMID: 16707777      PMCID: PMC2632246          DOI: 10.1093/schbul/sbj078

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  89 in total

1.  Clinical neuroscience and epidemiology in schizophrenia.

Authors:  L J Seidman
Journal:  Harv Rev Psychiatry       Date:  1997 Mar-Apr       Impact factor: 3.732

Review 2.  Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.

Authors:  P D Harvey; R S Keefe
Journal:  Am J Psychiatry       Date:  2001-02       Impact factor: 18.112

3.  Heritability estimates for psychotic disorders: the Maudsley twin psychosis series.

Authors:  A G Cardno; E J Marshall; B Coid; A M Macdonald; T R Ribchester; N J Davies; P Venturi; L A Jones; S W Lewis; P C Sham; I I Gottesman; A E Farmer; P McGuffin; A M Reveley; R M Murray
Journal:  Arch Gen Psychiatry       Date:  1999-02

4.  Neuropsychological risk indicators for schizophrenia: a preliminary study of female relatives of schizophrenic and bipolar probands.

Authors:  W S Kremen; S V Faraone; L J Seidman; J R Pepple; M T Tsuang
Journal:  Psychiatry Res       Date:  1998-07-13       Impact factor: 3.222

5.  Cognitive substrates of thought disorder, I: the semantic system.

Authors:  T E Goldberg; M S Aloia; M L Gourovitch; D Missar; D Pickar; D R Weinberger
Journal:  Am J Psychiatry       Date:  1998-12       Impact factor: 18.112

Review 6.  Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism.

Authors:  B T Woods
Journal:  Am J Psychiatry       Date:  1998-12       Impact factor: 18.112

7.  Hillside study of risk and early detection in schizophrenia.

Authors:  B Cornblatt; M Obuchowski; D Schnur; J D O'Brien
Journal:  Br J Psychiatry Suppl       Date:  1998

8.  Attentional abilities and measures of schizotypy: their variation and covariation in schizophrenic patients, their siblings, and normal control subjects.

Authors:  P Franke; W Maier; J Hardt; C Hain; B A Cornblatt
Journal:  Psychiatry Res       Date:  1994-12       Impact factor: 3.222

9.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

Authors:  R W Heinrichs; K K Zakzanis
Journal:  Neuropsychology       Date:  1998-07       Impact factor: 3.295

Review 10.  What are the functional consequences of neurocognitive deficits in schizophrenia?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

View more
  46 in total

1.  Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.

Authors:  Larry J Seidman; Anthony J Giuliano; Eric C Meyer; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Bruce K Christensen; Keith Hawkins; Robert Heaton; Richard S E Keefe; Robert Heinssen; Barbara A Cornblatt
Journal:  Arch Gen Psychiatry       Date:  2010-06

2.  Neurocognitive and clinical dysfunction in adult Chinese, nonpsychotic relatives of patients with schizophrenia: Findings from the Changsha study and evidence for schizotaxia.

Authors:  William S Stone; Xiaolu Hsi; Liwen Tan; Shaochun Zhu; Lingjiang Li; Anthony J Giuliano; Larry J Seidman; Ming T Tsuang
Journal:  Asian J Psychiatr       Date:  2012-03

3.  Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS).

Authors:  William S Stone; Anthony J Giuliano; Ming T Tsuang; David L Braff; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Stephen V Faraone; Robert Freedman; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Gregory A Light; Jim Mintz; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Andrea H Roe; Nicholas J Schork; Larry J Siever; Jeremy M Silverman; Neal R Swerdlow; Alison R Thomas; Debby W Tsuang; Bruce I Turetsky; Larry J Seidman
Journal:  Schizophr Res       Date:  2011-02-01       Impact factor: 4.939

Review 4.  Emotion processing in persons at risk for schizophrenia.

Authors:  Laura K Phillips; Larry J Seidman
Journal:  Schizophr Bull       Date:  2008-07-21       Impact factor: 9.306

5.  Advances in endophenotyping schizophrenia.

Authors:  David L Braff; Tiffany A Greenwood; Neal R Swerdlow; Gregory A Light; Nicholas J Schork
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

6.  Childhood abuse and neglect may induce deficits in cognitive precursors of psychosis in high-risk children.

Authors:  Nicolas Berthelot; Thomas Paccalet; Elsa Gilbert; Isabel Moreau; Chantal Mérette; Nathalie Gingras; Nancie Rouleau; Michel Maziade
Journal:  J Psychiatry Neurosci       Date:  2015-09       Impact factor: 6.186

7.  Cognitive changes following antidepressant or antipsychotic treatment in adolescents at clinical risk for psychosis.

Authors:  Christopher R Bowie; Danielle McLaughlin; Ricardo E Carrión; Andrea M Auther; Barbara A Cornblatt
Journal:  Schizophr Res       Date:  2012-02-28       Impact factor: 4.939

8.  The stability of inhibitory and working memory deficits in children and adolescents who are children of parents with schizophrenia.

Authors:  Randal G Ross; Brandie Wagner; Shari Heinlein; Gary O Zerbe
Journal:  Schizophr Bull       Date:  2007-09-14       Impact factor: 9.306

9.  Cognition in young schizophrenia outpatients: comparison of first-episode with multiepisode patients.

Authors:  Yoram Braw; Yuval Bloch; Shlomo Mendelovich; Gideon Ratzoni; Gilad Gal; Hagai Harari; Asaf Tripto; Yechiel Levkovitz
Journal:  Schizophr Bull       Date:  2007-11-05       Impact factor: 9.306

10.  Premorbid cognitive deficits in young relatives of schizophrenia patients.

Authors:  Matcheri S Keshavan; Shreedhar Kulkarni; Tejas Bhojraj; Alan Francis; Vaibhav Diwadkar; Debra M Montrose; Larry J Seidman; John Sweeney
Journal:  Front Hum Neurosci       Date:  2010-03-09       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.